Micheli Fabrizio, Di Fabio Romano, Cavallini Palmina, Cavanni Paolo, Donati Daniele, Hamdan Mahmoud, Maria Sabbatini Fabio, Messeri Tommaso
GlaxoSmithKline Medicine Research Centre, via Fleming 4, Verona 37135, Italy.
Farmaco. 2004 Feb;59(2):119-23. doi: 10.1016/j.farmac.2003.12.006.
Following the recent disclosure (Part I of this paper) of 3-methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) amides and of their improved pharmacokinetic profile with respect to the originally reported esters, a further exploration of the C-2 position through a solid-phase approach is reported here.